Drug intelligence / Profile preview

diclofenac + scopolamina

Development stage
Unknown
Lead developer
Virpax Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Diclofenac + scopolamina is a combination drug consisting of two active pharmaceutical ingredients: - **Diclofenac** is a nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting cyclooxygenase (COX-1 and COX-2) enzymes, leading to decreased synthesis of prostaglandins involved in pain, inflammation, and fever. It is widely used for the treatment of pain and inflammatory conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, dysmenorrhea, acute migraine attacks, postoperative pain, and other musculoskeletal disorders[3][6][8]. - **Scopolamine** (also known as hyoscine) is an anticholinergic agent that acts primarily as a competitive antagonist at muscarinic acetylcholine receptors. It inhibits parasympathetic nerve impulses responsible for smooth muscle contraction in the gastrointestinal tract and other organs. Scopolamine is mainly used to prevent nausea/vomiting associated with motion sickness or postoperative states but also has antispasmodic effects on smooth muscle[5]. The combination may be considered for situations where both analgesic/anti-inflammatory effects (from diclofenac) and antispasmodic/anticholinergic effects (from scopolamine) are desired—such as certain types of visceral or pelvic pain with spasm components. However, there are no widely recognized fixed-dose commercial products containing this exact combination; it may be compounded or co-administered off-label in some settings.

Other names
diclofenac and scopolaminediclofenac + scopolamine
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)mAChR (Muscarinic acetylcholine receptors)

Beyond the preview

Go deeper on diclofenac + scopolamina.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on diclofenac + scopolamina.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call